The FDA is unlikely to ask its outside vaccine advisers to weigh in on whether the agency should authorize Pfizer Covid-19 boosters for all adults, a source familiar with the situation told CNN. Pfizer applied to the FDA for emergency use authorization on November 9 to make all adults eligible for boosters. Processing that request could be faster if the agency does not wait for members of the Vaccines and Related Biological Products Advisory Committee to meet.